• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD ACETLR CUP HAP 46MM W/ IMPTR; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD ACETLR CUP HAP 46MM W/ IMPTR; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING Back to Search Results
Catalog Number 74120146
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Pain (1994); Scar Tissue (2060); Deformity/ Disfigurement (2360); Osteolysis (2377); Inadequate Osseointegration (2646)
Date of Event 01/15/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that, after a primary right bhr was performed on (b)(6) 2007, later the plaintiff started to experience pain that interfered with their daily activities, and radiographic evidence of femoral neck lucency was found.Therefore, a revision surgery was performed on (b)(6) 2024, during which both bhr components were exchanged for competitor devices.Excessive scar tissue was noticed around the cup and the cup was in a lateral position.No other complications were reported.
 
Additional Manufacturer Narrative
H10: internal complaint reference: (b)(4).
 
Additional Manufacturer Narrative
H3, h6: it was reported that, after a primary right bhr was performed, later the plaintiff started to experience pain that interfered with their daily activities, and radiographic evidence of femoral neck lucency was found.Therefore, a revision surgery was performed, during which both bhr components were exchanged for competitor devices.Excessive scar tissue was noticed around the cup and the cup was in a lateral position.No other complications were reported.As of today, the implanted devices, all of which were used in treatment have not been returned for evaluation.A review of the historical complaints data for the alleged devices was performed using batch numbers, part numbers and the reported failure modes to evaluate patterns of repeated failures or defects.Similar complaints have been identified for the head and no other similar complaints were identified for the cup.This will continue to be monitored via routine trending, however it should be noted that these devices are no longer sold.In the absence of the actual devices, the production records were reviewed for the devices reportedly involved in this incident.All released devices involved met manufacturing specifications upon release for distribution.The review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.A review of historic escalation actions related to the products and similar complaint events was performed.Following the review, prior applicable escalation actions were identified and confirmed to reduce associated risks as far as possible.No further escalation actions are required.The available medical documents were reviewed.The lateral position of the acetabular cup cannot be ruled out as a possible contributing factor to the reported pain and femoral neck lucency.However, without the implantation and pre-revision x-rays, initial implant anatomical placement and any micro-motion over time cannot be determined.The patient impact is the reported events and the revision.Based on the information provided, further investigation of the reported complaint cannot be carried out and remains inconclusive.A definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement.Should the devices or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACETLR CUP HAP 46MM W/ IMPTR
Common Device Name
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK  CV31 3HL
Manufacturer (Section G)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK   CV31 3HL
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key18791908
Report Number3005975929-2024-00029
Device Sequence Number7757743
Product Code NXT
UDI-Device Identifier03596010502544
UDI-Public3596010502544
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P040033
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2007
Device Explanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 03/18/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number74120146
Device Lot Number64225
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/05/2024
Supplement Date Received by Manufacturer03/12/2024
Initial Report FDA Received Date02/27/2024
Supplement Report FDA Received Date03/18/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
Z-2746-2015, Z-2745-2015
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
74121138/RESURFACING FEMORAL HEAD 38MM
Outcome Attributed to Adverse Event Required Intervention; Other;
Patient Age58 YR
Patient SexFemale
-
-